Guardant Health Raises $550M in Convertible Notes to Refinance Debt and Fuel Growth
Guardant Health raises $550M in debt, sells director shares, and rebalances debt to fund biotech growth—see how the firm is optimizing its capital structure.
2 minutes to read
